Moleculin Biotech
MBRX
MBRX
21 hedge funds and large institutions have $790K invested in Moleculin Biotech in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
40% less capital invested
Capital invested by funds: $1.31M → $790K (-$518K)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$46.9K | |
| 2 | +$15.2K | |
| 3 | +$8.69K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.76K |
| 5 |
Renaissance Technologies
New York
|
+$850 |
Top Sellers
| 1 | -$68.8K | |
| 2 | -$935 | |
| 3 | -$162 | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$66 |
| 5 |
Morgan Stanley
New York
|
-$39 |